Search

Each record is a registered study, a systematic-review registration or a publication. A registered or ongoing study is not a finding, and animal or cell research does not show an effect in people. The same study can appear under more than one subject, so the number of records is not a count of independent studies. You can also search an exact DOI, PubMed ID, NCT or CRD number. How to read these records.

9 study records (showing up to 30 per record type)

• Registered trial NCT06114576 Completed (results not assessed here)
  Effects of Biofunctional Orange Juice on Cardiometabolic Risk Markers
  Condition or outcome area: Overweight and Obesity|Prediabetes|Hypertension|Dyslipidemias
  2023-03-01 · Subject: Tian Cheng; 甜橙; Sweet Orange; Citrus Sinensis · open the herb record · ClinicalTrials.gov
• Registered trial NCT01778114 Completed (results not assessed here)
  Availability of Vitamin D in Orange Juice
  Condition or outcome area: Vitamin D Deficiency
  2006-12 · Subject: Vitamin D2; Vitamin D2 (6,19,19-d3) · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT04234100 Completed (results not assessed here)
  Bioavailability of Hesperidine and Narirutin From Orange Juice to Identify Metabotypes in Hypertension
  Condition or outcome area: Blood Pressure|Hypertension
  2020-02-24 · Subject: Narirutin; C09793; (2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-2-tetrahydropyranyl]oxymethyl]-2-tetrahydropyranyl]oxy]-4-chromanone; CHEBI:28705; LMPK12140236; (2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychroman-4-one; narirutin; Naringenin 7-O-rutinoside; 14259-46-2; (2S)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dih · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT00960193 Phase 1 Completed (results not assessed here)
  Drug-Food Interaction Study of Seville Orange Juice and Colchicine
  Condition or outcome area: Healthy
  2009-02 · Subject: Colchicine; LS-187917 · open the ingredient record · ClinicalTrials.gov
• Registered trial NCT01743300 Phase 1 Completed (results not assessed here)
  The Influence of Phenotype, Grapefruit Juice and Orange Juice on the Pharmacokinetics of Sunitinib in Cancer Patients
  Condition or outcome area: Healthy
  2007-07 · Subject: Pu Tao You; 葡萄柚; Grapefruit; Citrus Paradisi · open the herb record · ClinicalTrials.gov
• Systematic review registration CRD42020162376 Registered protocol, no results here: Review Ongoing
  The impact hesperidin consumption from 100% orange juice has on chronic diseases: A systematic review and gap analysis
  Condition or outcome area: arthritis, Alzheimer’s, cancer, cardiovascular disease, diabetes, and osteoporosis
  2020-04-28 · Subject: Hesperidin; 520-26-3; Cirantin; Hesperidoside; Hesper bitabs; Hesperetin 7-rhamnoglucoside; Hesperetin-rutinosid; Hesperidine; Hesperetin 7-rutinoside; Ciratin · open the ingredient record
• Systematic review registration CRD42017058191 Registered protocol, no results here: Review Ongoing
  The effect of hesperidin supplementation and orange juice on lipid profile and blood pressure: a systematic review and meta-analysis of clinical trials
  Condition or outcome area: Dyslipidemia and hypertension are known as a main risk factors for incidence of cardiovascular diseases (CVD). Dietary recommendations are the critical strategy to control of CVD risk factors through modification of atherogenic lipid profile and reduction of hypertension. Previous evidence suggests that hesperidin and orange juice may have beneficial effect in reducing the lipid profile and blood pressure.
  2017-02-28 · Subject: Hesperidin; 520-26-3; Cirantin; Hesperidoside; Hesper bitabs; Hesperetin 7-rhamnoglucoside; Hesperetin-rutinosid; Hesperidine; Hesperetin 7-rutinoside; Ciratin · open the ingredient record
• Systematic review registration CRD42017059923 Registered protocol, no results here: Review Ongoing
  Effects of hesperidin and orange juice supplementation on inflammatory markers: a systematic review and meta-analysis of clinical trials
  Condition or outcome area: Systemic inflammation plays an important role in development of several chronic diseases such as cardiovascular disease, bone disease, cancers and neurological disorders. Inflammatory markers can predict future cardiovascular events. Several environmental factors are associated with chronic inflammation (e.g. smoking, sedentary lifestyle, poor diet, weight gain and obesity). Recently anti-inflammatory foods such as fiber, fruits, vegetables and teas have been investigated. It has been shown that
  2017-03-21 · Subject: Hesperidin; 520-26-3; Cirantin; Hesperidoside; Hesper bitabs; Hesperetin 7-rhamnoglucoside; Hesperetin-rutinosid; Hesperidine; Hesperetin 7-rutinoside; Ciratin · open the ingredient record
• Systematic review registration CRD42017058859 Registered protocol, no results here: Review Ongoing
  Effects of hesperidin and orange juice supplementation on glycemic control: a systematic review and meta-analysis of clinical trials
  Condition or outcome area: Diabetes results from heterogeneous group of metabolic disorders which is closely related to atherosclerosis and coronary heart disease. Diabetes mellitus is increasing in prevalence throughout the world rapidly. The appropriate management of hyperglycemia by dietary recommendation are particularly important.
  2017-03-18 · Subject: Hesperidin; 520-26-3; Cirantin; Hesperidoside; Hesper bitabs; Hesperetin 7-rhamnoglucoside; Hesperetin-rutinosid; Hesperidine; Hesperetin 7-rutinoside; Ciratin · open the ingredient record